• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NovaBay Pharmaceuticals Inc

+ Add to Watchlist


0.6400 USD 0.0100 1.54%

As of 20:04:02 ET on 12/26/2014.

Snapshot for NovaBay Pharmaceuticals Inc (NBY)

Open: 0.6600 Day's Range: 0.6297 - 0.6600 Volume: 132,035
Previous Close: 0.6500 52wk Range: 0.5251 - 1.4700 1-Yr Rtn: -47.54%

Stock Chart for NBY

No chart data available.
  • NBY:US 0.6400
  • 1D
  • 1M
  • 1Y
Interactive NBY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NBY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3304
Est. EPS (USD) (12/2014) -0.3000
Est. PEG Ratio -
Market Cap (M USD) 33.04
Shares Outstanding (M) 51.63
30 Day Average Volume 128,703
Price/Book (mrq) 5.7525
Price/Sale (ttm) 26.5211
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NBY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NBY

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay Pharmaceuticals has developed a class of antimicrobial compounds for use in the treatment and prevention of bacterial infections.

Ramin Najafi "Ron"Chairman/President/CEOThomas J PaulsonCFO/Treasurer/Secretary
Roy J WuSenior VP:Bus & Corp DevDavid W StromanSenior VP:Ophthalmic Product Dev
More Company Profile & Key Executives for NBY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil